|
Market Cap (2-Jul) $71,840,344 (1,153rd) |
Close (30-Jun) $0.025 |
Volume (30-Jun) 981,823 |
Shortsold (10-Jun) 33,792 (0.00%) (569th) |
|
52w High $0.060 |
52w Low $0.024 |
P/E - |
EPS -0.01 |
PCK released this announcement to the ASX on 22 January 2021, 10:27. The announcement is marked as price sensitive, and is 22 page(s) in length and 2.5MB in size.
You can view all announcements from PCK and see how they appear on a price chart on the announcements page.
At the date of this announcement, PCK was 0.263% short sold according to ASIC data. It was ranked the 345th most shorted stock on the ASX. It remains ranked 569th as of the latest reported data (10 June 2025).
| Other Recent Announcements from PCK | |
|---|---|
| Ethos Laboratories Distribution Agreement | 15 June 2023, 10:52 |
| Investor Presentation Webinar | 2 May 2023, 8:31 |
| Quarterly Investor Webinar - Tuesday 2 May | 28 April 2023, 16:30 |
| Presentation - December 2020 Quarter Update | 22 January 2021, 10:27 |
| December 2020 Quarterly Update | 22 January 2021, 10:24 |
| Appendix 4C - quarterly | 22 January 2021, 10:17 |
| Successful Completion of Infant Face-Only Clinical Study | 22 January 2021, 8:22 |
You must be logged in to post a reply.
PainChek 